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Summary.-Chromosome changes in human cancer cells appear to evolve by non-
random losses and/or gains of particular homologues or groups. It is probable that
some ofthe apparent losses or gains actually represent formation of new chromosome
structures, which are then classified as markers or are misclassified as normal
homologues. In many cancers these changes appear to continue at a high rate
throughout the life of the cancer (so that in some cancers almost everycellwillexhibit
a different karyotype). In other cancers the rate of change may be slow or arrested
so that all cells will have the same abnormal karyotype. One very common step in
karyotype evolution is doubling of the entire chromosome complement (2n -+ 4n or
more commonly, S -- 2S where S is the stemline number). The 2S cells tend to
replace the original stemline. Homologues which have larger amounts of con-
centrated blocks of heterochromatin (i.e. late replicating DNA) seem more apt to
be lost.
SO FAR no single feature has been
found which distinguishes human cancer
cells from benign cells. However, a large
majority of human cancers are charac-
terized by gross chromosome abnormali-
ties. The resultant karyotype abnor-
malities are far more unbalanced than
are those which occur in benign somatic
cells. Indeed, one may plausibly suspect
that were such changes to occur in benign
cells, they would prove lethal to these
cells. Thus, the capacity of cancer cells
so affected to survive may be a peculiarity
of cancer. An understanding of the
evolution of such changes and of the
mechanisms which produce them may
help to elucidate the nature of the
oncogenic state. Van Steenis (1966) and
Levan (1966) have published statistical
analyses based respectively on 26 and 40
cases originally described by Makino,
Sasaki and Tonomura (1964) and Ishihara,
Kikuchi and Sandberg (1963). Atkin
and Baker (1969) have reported a similar
analysis of a different series. In essence,
these authors found that the chromosome
changes in human cancer were not
random. Rather, some homologues or
groups of chromosomes tended to undergo
losses, i.e., the acrocentric chromosomes
(13-15 and 21-22 + Y) and the B(4-5)
group, while some others tended to be
augmented, particularly the 6-12 + X
group. Muldal, Elejalde and Harvey
(1971) have reported similar findings for
5 cases. The following report analyses
karyotypes on 21 additional cases origin-
ally reported elsewhere.
MATERIALS AND METHODS
Table I lists cases and karyotypes. All
of these analyses were based on direct
chromosome preparations, without in vitro
culture. Seven of the analyses were of
solid tumours, 6 primary and 1 metastatic
(or recurrent); 14 analyses were of cancer
cells in effusion. Only karyotypes with
chromosome abnormalities were analysed
(thus, tumours with presumed normal stem-
line karyotypes were omitted). Descriptions
of some of these karyotypes have been
reported previously (Miles, Geller and O'Neill,
1966; Miles, 1967a, b; Miles and Wolinska,
1973).74 C. P. MILES
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Karyotyping was carried out by cuttiIng
out chromosomes and arranging them by
centromere position, and by comparison
with normal karyotypes from benign cells.
Karyotypes w"ere made for 194 cells in 21
cases, with 5 or more cells per case. Addi-
tional reference will be made to 52 cases in
which only 1-4 cells were available per
case. In a preliminary analysis chromo-
somes were designated as " markers " if
they did not resemble any normal homologue.
In a revised analvsis markers were classified
as: (1) Minute chromosome, i.e. less than
one-half the size of a 21-22 group chromo-
some (for acrocentric minutes) or less than
one-half the size of a 19-20 group chromo-
some (for metacentric or submetacentric
minutes); (2) fragments, i.e. paired chro-
matids usually the size of minutes but
without visible centromeres; (3) acrocentric
chromosomes other than groups 13-15 or
21-22 chromosomes; (4) metacentric and
submetacentric chromosomes larger than
chromosome No. 1; (5) ring chromosomes;
(6) dicentric chromosomes; (7) multiradial
chromosomes.
The revised analysis was an attempt to
rule out as far as possible the erroneous
placing of unaltered homologues in the
market group.
The method of statistical analysis em-
ployed was in general that of Van Steenis
(1966) and of Levan (1966). The problem
posed is that we do not as yetunderstand
the biological mechanisms which induce
chromosome abnormalities in cancer. On
the simplest assumption, these mechanisms
should affect all chromosomes equally. Thus,
if we find that the number of chromosomes
in a cancer cell is 92, twice the expected 46,
then we might expect each homologue to be
doubled. Similarly, if the number is 69,
we might expect one extra homologue for
each pair ofhomologues. It is probable that
there are a number of mechanisms at w%ork
and that the effects are to some extent
random. Thus, a particular mechanism may
affect one chromosome on one occasion and
a different homologue on another. More-
over, cancer cells when abnormal usually do
not contain integral multiples of the haploid
or diploid number. That is, they are
seldom precisely 3n, 4n, 5n or the like, and
therefore, in any given case we cannot expect
all homologues to be affected to the same
degree. Nevertheless, if we average a suffi-
6
cient number of cancer cases, on the simplest
assumption, no chromosome group or homo-
logue should be affected more than another.
The type of analysis employed is as
follows: If there are several substantially
similar karyotypes for a given cancer, the
average number of chromosomes per cell
is first determined. Next, the abnormal
unclassifiable, i.e., marker, chromosomes are
subtracted from the total. Ideally, wie
wNould like to know the origin ofsuch markers
and to assign them to the homologues or
groups of origin. Usually, of course, w%e
do not know or can only speculate as to
origins; hence the markers must simply be
left out of account. Next, the expected
percentage of No ls, No. 2s, 4-5s, etc. is
calculated allowing for an extra 6-12 chro-
mosome in females and an extra small
acrocentric chromosome in males. Thus,
since there are normally 2 No. 1 homologues,
No. Is are expected to constitute 2/46 or
0 0435 of the total. The fraction of No. Is,
No. 2s, etc. in each stemline karyotype is
then calculated. If, in a given tumour,
cells with quite different karyotypes were
found, separate calculations were made for
each cell and the differences were then
averaged for the case. Thus, in the final
summary equal wAeight was given to each
case. In actual practice, the absolute numbers
of chromosomes for each cell were recorded
on standard IBM data cards and the desired
calculations were performed by computer at
the University of Utah Computer Center.
The correlation matrices were made at the
Health Sciences Computing Facility, Univer-
sity of California, Sain Francisco.
RESULTS
Non-randomness of chromnosome changes
Various homologues or chromosome
groups are not represented in the expected
proportions in the average cancer cell.
This is shown in Table II. The 4-5 group
shows the greatest deficit. All relative
losses rank from greatest to least: 4-5; 1;
21-22 + Y; 13-15; 3; 2; with relative
gains ranking from greatest to least:
6-12 + X; 19-20; 16-18. As may be
seen in Table II, these discrepancies are
highly significant for chromosome 1 and
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TABLE II.- Summary of Ranking, Losses
to Gains, Various Groupings
Chromosome
number
2
3
4-5
6-12+X
13-15
16-18
19-20
21-22+Y
AMean
-0-603
-0 -063
-0-133
-0-828
+2-230
-0-488
+0-460
+0-427
-0-552
T Value
-5-92
-0 63
-1-62
-4-72
4-58
-1-65
0- 23
1-59
-2-00
P Value
0000
0 535
0- 112
0-000
0000
0-106
0 823
0-120
0-052
Overall: 4-5, 1, 21--22+Y, 13-15, 3, 2, 16-18,
19-20, 6-12X-X.
groups 4-5 and 6-12 + X. They are not
significant for chromosome 2 and for
group 16-18 but are close to significant
for the other chromosomes or groups.
However, if 52 cases with 4 or fewer cells
are included, the ranking of changes is
very similar (i.e. 4-5; 13-15; 1; 21-22+Y;
2; 3; 16-18; 19-20; 6-12 + X) and all
the deviations are significant except for
chromosome 3 and group 16-18 (for most
at P < 00C01; for 19-20 and 21-22 + Y,
atP < 003).
(For these 52 cases calculated separ-
ately, the rankings are the same except
that 19-20 precedes 16-18, and the
deviations are significant except for chro-
mosome 3 and groups 21-22 + Y).
Thus, the chromosome changes occur-
ring in human cancer cells are distinctly
non-random. The ranking of these non-
random changes is similar with various
classifications of the tumours. Separate
calculations for lymphomata, melano-
mata and breast cancer yield very similar
rankings, and where a group appears
out of rank (i.e. 21-22 + Y in lympho-
mata) the deviation from expectation for
this group is not statistically significant.
(The actual rankings are: lymphomata:
4-5, 1, 13-15, 2, 3, 19-20, 16-18, 21,
21-22 + Y, 6-12 + X; melanomata: 4-5,
13-15, 1, 21-22 + Y, 2, 3, 19-20, 16-18,
6-12 + X; breast: 4-5, 1, 21-22 + Y,
13-15, 2, 3, 16-18, 19-20, 6-12 + X.)
Bimodal distribution of stemlines and
homologues
The distribution of stemline numbers
is bimodal (Fig.). There are no cases
with stemline nuimbers between 61 and 64
(although there are a few individual cells
within this range). Although no cases
with classically diploid stemlines were
analysed, even if we omit cases with
stemlines at 46 the distribution remains
distinctly bimodal.
Correlations of homologue or group changes
A correlation matrix for the total
data (i.e. including cases with fewer than
5 cells) showed a positive correlation of
0 61 between the 6-12 + X and the
16-18 groups, 0 57 between the 2s and
the 19-20 groups, 0 54 between the 13-15
and the 21-22 + Y groups, and 0-52
between the 16-18, and the 19-20 groups.
All the other correlations were less than
05. Thus, there is a tendency for the
least affected (less often lost) groups to
show positive correlation. This might be
expected since if there are two groups of
karyotypes, one of which is largely the
double of the other, then we would have
most often, for example, 2 No. 2s and 4
19-20s in one group with 4 No. 2s and 8
19-20s in the doubled group. Thus, the
change in the 2s would correlate with
the change in the 19-20s. The correla-
tion between the 13-15 and 21-22 + Y
groups is discussed below. Correlations
of homologues resulting from a mixture
of near-2n and sub-4n cells, as in the
correlation matrix for the total data,
would be less pronounced if the two
groups are separated. If 60 is chosen
as the dividing line, for stemlines greater
than 60 the strongest positive correlation
(0.46) is between the 13-15 and the
21-22 + Y groups. This would be ex-
pected if a long and short acrocentric
tend to leave the karyotype together, as
for example via a centric fusion
mechanism. (The next ranking positive
correlations are between the chromosome
No. 2 and the 19-20 group, 0 42, and
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between chromosome No. I and the 4-5
group, 0-41. None of the others are
greater than 0.4.) Correspondingly, the
largest negative correlation, 0 37, is
between the 21-22 + Y group and the
19-20 group. This would be expected if
two 21-22 (small acrocentric) chromo-
somes were to fuse and thus mimic a
19-20 (small metacentric) chromosome.
It should be emphasized that while such
data are consistent with a centric fusion
hypothesis, otherexplanationsare possible.
Moreover, in the matrix for stemlines less
than 60 the largest correlations admit of
no ready explanation (i.e. chromosome
No. 3 4-5 group equals 0-67; 6-12 +
X- 19-20 groups equals 0-58; 16-18-
21-22 + Y groups equals 0.48).
Correlations with marker chromosomes
Abnormal marker chromosomes in
cancer cells presumably represent normal
homologues which have become altered
by fusion, augmentation, translocation,
inversion etc. In some instances they
may represent homologues which have
simply been erroneously assigned to the
marker group either through simple error
or because of variations in degree of
condensation of part or all of the chromo-
some. It might be expected that the
number of markers would tend to increase
with the degree of chromosome abnor-
mality in the cell. Therefore, there
would be better correlation of markers
with chromosomes which are in relative
excess than with chromosomes which are
1) c;
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in deficit. In fact the correlations with
markers from negative to positive are:
4-5 ( 012); 1 ( 0.08); 13-15 ( 0.06);
21-22 + Y ( 0 02); 3 (+014); 2
(+0 26); 6- 12 + X (+0-41); 19-20
(+0-44); 16-18 (+0 45). The trend, at
any rate is similar to that for losses
and gains of various homologues or
groups (Table II). It is consistent with
the possibility that some of the lost
chromosomes appear, perhaps restruc-
tured, among the markers.
Table III shows the strongest negative
correlations. The findings are somewhat
different from the correlations of un-
classified markers with all 73 cases. In
particular, the long acrocentric 13-15
group chromosomes no longer show so
strong a negative correlation with markers
(thus suggesting possible erroneous classi-
fications in the original karyotypes).
The correlations suggest that minutes and
fragments often result from breaks in
16-18 chromosomes or, in the case of
fragments, from 21-22 chromosomes.
Similarly, acrocentric markers are more
often formed from chromosomes 1 and 2.
At the same time the finding of strong
negative correlations between metacentric
and submetacentric markers and chromo-
somes 1, 3 and 4-5 suggest the possibility
that some of these markers are not
restructured chromosomes but simply Is,
3s, or 4-5s which are not fully condensed.
Table IAT shows positive correlations
between markers, and suggests that the
same mechanism which produces frag-
ments also produces minute chromosomes.
A similar argument would apply for
various other markers.
DISCUSSION
It is postulated that cancer karyotypes
evolve through a process of mutation and
selection. At any stage of this process,
a doubling of the chromosome comple-
ment may occur (32 of these 73 cases
involved a doubling if we assume that a
stemline greater than 60 indicates
doubling). Cells with the doubled com-
plement may then ultimately replace the
cells with lower chromosome numbers.
Whether near-2n or sub-4n, the tumours
tend to gain or lose chromosomes by
various mechanisms, some of which will
be discussed. Most homologues or groups
are relatively unstable with a tendency
to lone chromosomes.
The evidence for a doubling mechanism
TABLE III.-Markers, Negative Correlations, Significant at Least at 50/ Level. The
Suggestion is that the Markers may be Arising from Homologues with which they are
Negatively Correlated
Minutes 16-18 (0 43, <60)
Fragments 6-18 (-036, <60); 21-22+Y (-0 47)
Aciocentrics (other than 13-15's or 21-22+Y's) 2 (0 45<60); 1 (0-38, >60)
Metacentrics and submetacenltrics larger than Is :3 (0 54, < 60); 4-5 (- 0-52, < 60); 1 (- 0-42, > 60)
Rings 3 0 38, < 60)
Dicentrics 3 0 43, > 60)
(N.B. The largest negative correlation of one marker wNith another marker was acrocentrics (other
than 13-15's or 21--22 +Y's) (dicentrics: -0*1239.)
TABLE IV. Markers, Positive Correlations, Significant at Least at 5%0 Level. Such
Correlations are Consistent with the Thesis that the Correlated Markers, Homologues
(Pseudo-homologues?) or Aberrations may be Induced by the Same Mechanism
Minutes Fragments (0-87, <60); 2 (0-41, <60)
Fragments Acrocentrics (other than 13-15 or 21-22) (0-46, > 60)
Metacentrics and submetaceintrics larger than Is Acrocentrics (other than 13-15 or 21-22) (0-52, > 60)
Rings (0-46, <60)
Dicenitrics 4-5 (0 41, > 60)
Multiradials Acrocentrics (other tharn 13-15 or 21-22) (0 44, > 60)
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is: (1) The bimodal distribution of stem-
line numbers (Fig.) (see also Atkin and
Ross, 1960); (2) the occasional finding
of S and 2S stemlines in the same tumour
(Miles et al., 1966; Miles, 1967a. b; Atkin
and Ross, 1960); (3) the finding of the
same marker represented twice in the
same cell (Miles, 1967a, b; (4) the occa-
sional finding of 4n or near-4n tumours
(Miles et al., 1966; Spiers and Baikie,
1968; Lubs and Clark, 1963; Spriggs,
Boddington and Clarke, 1962; Lubs and
Salmon, 1965; Ricci et al., 1962).
It is probable that after a tumour has
doubled its stemline, the strongest ten-
dency is to lose (rather than gain) chromo-
somes. This would appear to be true
because there is only one tumour with a
stemline less than 42, whereas there are
at least 24 tumours which have doubled
their original stemlines judging from the
Fig. and yet have stemlines less than 84
(i.e. 2 x 42). A sequence of: 2n (or
near-2n) -+ 4n (or near-4n) -* less than
4n, is more likely than a sequence of
2n etc. - 3n, since precisely 3n (i.e.
classic triploidy) or even very near 3n
cancer cells are not found.
Whether the stemline is near-2n or
near-4n (usually sub-4n), various other
mechanisms work to alter the karyotype.
Levan (1966) suggests one mechanism
which may play a significant role in
these changes. This is the tendency for
centric fusion (fusion of or near the short
arms) of acrocentric chromosomes. If a
small acrocentric (21-22) fuses with a
large acrocentric (13-15), the resultant
marker might well mimic a 6-12 + X
group chromosome (or possibly a No. 16
chromosome if some material were lost).
This mechanism could account for the
loss of acrocentrics and the relative
gains in the 6-12 + X and 16-18 groups.
Also, as would be expected from loss
of 13-15s and 21-22s through fusion,
there is positive correlation between the
numbers of 13-15 and 21-22 chromo-
somes. Although there is not a strong
negative correlation between acrocentric
(13-15 and 21-22) and 6-12 + X group
chromosomes, this is not surprising since
the loss through centric fusion of a 13-15
and 21-22 chromosome results in only a
small percentage gain to the 6-12 + X
group. However, when small acrocentrics
(21-22 group) fuse to form small meta-
centric chromosomes (resembling 19-20s)
the percentage changes are much greater.
In this instance there is a significant
negative correlation between small meta-
centrics and small acrocentrics for cases
with stemlines greater than 60 (Table
III).
At least two mechanisms might ac-
count for loss of chromosome No. 1.
One is the apparent tendency for increase
ofthe length ofthe long arm, thus forming
a marker chromosome, the Madison or
RM-1 chromosome (Miles, 1967a). The
extra length may be due to duplications
of the heterochromatin segment. Another
mechanism might be pulverization of the
long arm or the entire chromosome such
as occurs in some human leucocyte cell
lines (Miles and O'Neill, 1969), or a break
at the heterochromatin segment of the
long arm with a fusion of the distal long
arm to a small acrocentric as is seen in
the cell line LKI1D (Miles et al., 1968).
The sequences of losses and gains for
homologues in cancer cells appear to
bear some relation to the heterochromatin
(in the sense of late labelling chromatin)
of the chromosomes. Late label per unit
length of chromosomes is as follows:
4-5, 13-15, 6-12 + X, 3, 2, 16-18, 21-22,
1, 19-20 from largest to smallest amounts
(Miles, 1970). This compares with 4-5, 1,
21-22 + Y, 13-15, 3, 2, 16-18, 19-20,
6-12 + X for losses and gains (21 cases
with 5 or more cells). Groups or homo-
logues 4-5, 13-15, 3, 2, 16-18, and 19-20
are in the same order. While chromo-
some No. I has a smaller total amount
of late replicating chromatin, it has a
very prominent late replicating segment
of the long arm near the centromere.
It has been argued that heterochro-
matin segments are more apt to be
broken (Gilbert et al., 1962). This could
lead to losses and to formation of marker
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chromosomes. Centric fusion may be
preceded by a heterochromatin break in
the short arms of the involved acro-
centrics (White, 1954). Attenuated
secondary constrictions have been noted
in many cancer cells (Miles et al., 1966;
Miles, 1967a; Spiers and Baikie, 1968)
and some of the more common of such
constrictions (chromosomes Nos 1 and
16) are associated with heterochromatin
segments. These constrictions may be
of particular interest in view of their
inducibility by viruses (O'Neill and Miles,
1969).
If, as has been postulated (O'Neill and
Miles, 1970), pulverization results from
forced mitotic condensation of chromo-
somes before DNA synthesis is complete,
then late replicating segments would be
more apt to be pulverized. The promi-
nent heterochromatin segment on the
long arm of chromosome No. 1 has been
alluded to, and the long arm is particu-
larly susceptible to pulverization (Miles
and O'Neill, 1969). (This assumes, of
course, that in some instances the ap-
pearance of pulverization may actually
represent fragmentation of the affected
chromosome.)
If indeed heterochromatin areas are
preferentially affected, one possible ex-
planation relates to the supposed genetic
inertness of heterochromatin. It is pos-
sible that both euchromatin and hetero-
chromatin areas are equally affected but
that euchromatin damage tends more
often to be lethal. Selection might then
give the appearance ofpreferential damage
to heterochromatin. One approach to
answering this question might be to
study the distribution of short-term
damage effects, such as multiradials and
fragments.
Conceivably the cytogenetic processes
leading to karyotype abnormalities in
cancer do not differ from those occurring
in benign cells. Rather, these processes
are simply greatly speeded up in many
cancers.
It should be mentioned that some
studies either do not confirm non-random
changes or elsereport a somewhat different
effect. Sandberg et al. (1968) did not
find evidence for centric fusion in an
analysis of 26 cases of human cancer.
Minkler, Gofman and Tandy (1970)
report a marked excess of chromosome
No. 16 in their series; other imbalances
were not consistent. Their method of
karyotyping is certainly more objective
than that usually employed and it is
possible that they have more often cor-
rectly assigned small submetacentric chro-
mosomes to the 16 than to the 12 position.
On the other hand, their series includes
17 cell lines, many of which may be of
common origin (Gartler, 1968). There
were only 11 cases with direct prepara-
tions. Perhaps, with more cases, other
significant changes might have been
detected. Moreover, Bender, Kasten-
baum and Lever (1972) were not able to
confirm the accuracy of the karyotyping
method when employed on benign diploid
cells.
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